En Carta Diagnostics

🌞 Summer is finally here! 🌞 The #Paris2024 #Olympics may be in full swing, but #EnCartans are taking a well-deserved break to recharge! As we dive into the summer holidays, many of us will enjoy the great outdoors with family and friends. Whether you're hiking, picnicking, or relaxing at the beach, stay vigilant about #ticks and #Lyme! 🌳 Our Tips for Tick-Free Summer: - Wear light-colored clothing to spot ticks easily. - Use insect repellent on skin and clothing. - Perform regular tick checks, especially after being outdoors. Your health matters to us, which is why we put all our efforts into next generation Point-of-Care molecular tests! While you wait for our breakthroughs to hit the market, have a wonderful and safe summer from all of us at En Carta Diagnostics. 🏖️🦋 #TickAwareness #HealthySummer #LymeDiseasePrevention #EnCartaDiagnostics #PointOfCare #HealthcareInnovation

#ECDInsights 𝐒𝐞𝐫𝐢𝐞𝐬 🚀 𝐓𝐡𝐞 𝐓𝐢𝐦𝐞-𝐒𝐚𝐯𝐢𝐧𝐠 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐨𝐟 𝐏𝐨𝐢𝐧𝐭-𝐨𝐟-𝐂𝐚𝐫𝐞 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 🚀 Time is free, but it is also priceless. That is why in today’s episode of #ECDInsigths Series we will talk about how Point of Care (POC) solutions bring game-changing time benefits to the healthcare world. Finding ways to deliver accurate diagnoses swiftly without compromising on quality is a critical aim of testing. This is where POC diagnostics shine. Here are some compelling time-saving benefits: 𝐈𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞 𝐑𝐞𝐬𝐮𝐥𝐭𝐬 ⏱️ Unlike traditional lab tests that can take hours or even days, POC diagnostics provide results within minutes. This speed can make a world of difference in personally sensitive infections, like STIs, where prompt answers reduce uncertainty, anxiety and stigma, and inform the patient’s next steps. Not to mention the critical role of time in emergency situations, allowing for prompt, often life-saving, medical intervention. 𝐎𝐩𝐭𝐢𝐦𝐢𝐳𝐞𝐝 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐉𝐨𝐮𝐫𝐧𝐞𝐲 🏥 Efficient and accurate POC diagnostics, combined with telehealth ecosystem, have game-changing potential for optimization of decision making in healthcare. Reliable diagnosis in the field, or in comfort of our own home, removes significant burden from GP offices and hospitals, allowing for more patients to be seen, diagnosed, and treated in less time, reducing waiting periods, improving overall patient satisfaction, and often preventing the need for prolonged hospital admissions. This not only frees up valuable resources but also reduces healthcare costs. 𝐄𝐦𝐩𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐑𝐞𝐦𝐨𝐭𝐞 𝐚𝐧𝐝 𝐑𝐮𝐫𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 🌍 POC diagnostics bring quality healthcare to remote and underserved areas. By providing on-the-spot results, healthcare workers in these regions can make immediate and informed decisions, improving patient outcomes and accessibility. 𝐎𝐩𝐭𝐢𝐦𝐢𝐳𝐞𝐝 𝐑𝐞𝐬𝐨𝐮𝐫𝐜𝐞 𝐔𝐭𝐢𝐥𝐢𝐳𝐚𝐭𝐢𝐨𝐧 📈 By streamlining the diagnostic process, healthcare facilities can better allocate their resources. This efficiency allows for better management of staff, equipment, and finances, ultimately leading to a more effective healthcare system. POC diagnostics represent a significant leap forward in healthcare, providing rapid, reliable results where and when they are needed most. As we continue to innovate and integrate these solutions at En Carta Diagnostics, the future of healthcare looks brighter, faster, and more efficient. Stay tuned and follow us for more #ECDInsights! Let’s learn together how cutting-edge deeptech innovations help shape the future of healthcare! #EnCartaDiagnostics #PointOfCare #HealthcareInnovation #SustainableHealthcare #TimeSavingSolutions #MolecularDiagnostics

🔍 GREAT JOB ALERT! At En Carta Diagnostics we are on a mission to revolutionize healthcare with innovative molecular diagnostics that address significant unmet needs. Now it is the time to join us! 🚀 𝐏𝐨𝐬𝐢𝐭𝐢𝐨𝐧: 𝐇𝐞𝐚𝐝 𝐨𝐟 𝐐𝐮𝐚𝐥𝐢𝐭𝐲 𝐚𝐧𝐝 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐀𝐟𝐟𝐚𝐢𝐫𝐬 (𝐐𝐀/𝐑𝐀) We are seeking a dynamic, organized, and motivated professional to lead our QA/RA efforts. The ideal candidate will excel in managing IVDR for point-of-care tests and align with our company values. If you’re proactive, detail-oriented, and excited to solve real-world problems with cutting-edge research, apply now! All of the details can be found in the file below! #Hiring #QA #RegulatoryAffairs #SyntheticBiology #HealthcareInnovation #JoinOurTeam #EnCartaDiagnostics #EnCartans Paris Biotech Santé 50 Partners 50 Partners Health PC'up - Incubateur ESPCI Paris Leia Capital

#ECDInsights 𝐒𝐞𝐫𝐢𝐞𝐬 𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐨𝐟 𝐏𝐨𝐢𝐧𝐭 𝐨𝐟 𝐂𝐚𝐫𝐞 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬   In today’s healthcare landscape, the need for efficient and cost-effective solutions has never been greater. Point of Care (POC) diagnostics stand out as a real game-changer in this regard.   𝐇𝐞𝐫𝐞’𝐬 𝐡𝐨𝐰 𝐏𝐎𝐂 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐜𝐚𝐧 𝐦𝐚𝐤𝐞 𝐚 𝐬𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭 𝐞𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐢𝐦𝐩𝐚𝐜𝐭:   🔍 𝐒𝐲𝐬𝐭𝐞𝐦𝐢𝐜 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐨𝐟 𝐄𝐚𝐫𝐥𝐲 𝐃𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐄𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐭 𝐓𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬: By enabling early pathogen detection, POC diagnostics have tremendous power to improve and simplify patient’s journey and treatment outcomes and with this, significantly reduce long term financial burdens on healthcare systems. The trend was recently exemplified in a comprehensive WHO analysis of the economical impact of the early POC HIV detection in infants.   💡 𝐋𝐨𝐰𝐞𝐫𝐞𝐝 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐂𝐨𝐬𝐭𝐬: Traditional lab tests often come with high costs and delays. POC diagnostics streamline this process, cutting down expenses significantly through their simplicity. Bypassing the laboratory-specific technicalities allows also for democratization of diagnostic solutions by bringing quality healthcare directly to the patients, and empowering them to take an active role in managing their health.   🏥 I𝐦𝐩𝐫𝐨𝐯𝐞𝐝 𝐑𝐞𝐬𝐨𝐮𝐫𝐜𝐞 𝐀𝐥𝐥𝐨𝐜𝐚𝐭𝐢𝐨𝐧: With faster diagnostics, the burden on hospitals and GPs is greatly improved, enabling healthcare providers, doctors and nurses to allocate their time and resources more efficiently, focusing on critical cases and optimizing their operations.   At En Carta Diagnostics, we’re committed to revolutionizing healthcare with our cutting-edge POC solutions. In the landmark Zika virus trial, led by our co-founders Margot Karlikow, PhD and Keith Pardee, our field-based tests reached qPCR-like quality while cutting the costs in half compared to the gold standard (read more about the study below). These results not only underlined the potential for improved patient outcomes but also showcased the tangible economic benefits of POC diagnostics. https://lnkd.in/eDKhFbuc   Stay tuned for more #ECDInsights!   #HealthcareInnovation #PointOfCareDiagnostics #CostSavings #PatientCare #EnCartaDiagnostics #BetterCareEverywhere #EnCartans

👋 Hello World, and welcome back to our #ECDInsights series, where we dive deep into all things related to Point of Care (POC) diagnostic solutions! In our kickoff post last week, we highlighted the incredible benefits of POC diagnostics. These advantages raise an important question - why are these solutions not in every home yet? Let’s explore this together! 💡 𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐛𝐢𝐠𝐠𝐞𝐬𝐭 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐟𝐨𝐫 𝐏𝐎𝐂 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬? 𝐀𝐜𝐜𝐮𝐫𝐚𝐜𝐲 𝐚𝐧𝐝 𝐑𝐞𝐥𝐢𝐚𝐛𝐢𝐥𝐢𝐭𝐲: Ensuring that POC diagnostic tools provide results as accurate and reliable as those obtained from traditional laboratory tests is critical. Both, the technological advancements needed to reach high laboratory-like standards, and additional factors, such as environmental conditions, non-professional operator handling, and variable sample quality, can be important obstacles that need to be overcome. 𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐢𝐥𝐢𝐭𝐲: Most POC solutions need to self sufficiently run the test, while in nature being a single use device. This creates challenges for waste production and management, especially that a lot of the components are often built of plastic. Best emerging POC tools will be designed with the environment in mind, striving to find eco-friendly materials and processes, with the aim of minimizing the environmental impact. 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐥𝐥𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐇𝐚𝐧𝐝𝐥𝐢𝐧𝐠: In science we often say that the analysis can only be as good as the data provided. Diagnostic testing is no different, and that is why collecting samples is one of the most critical steps. Ensuring the appropriate quality of the testing sample in the field is not a trivial task, and great innovative effort is put into optimizing sample collection and extraction technologies for POC diagnostics. 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐚𝐧𝐝 𝐏𝐫𝐨𝐯𝐢𝐝𝐞𝐫 𝐀𝐜𝐜𝐞𝐩𝐭𝐚𝐧𝐜𝐞: We are naturally scared of the unknown, and so there can be resistance to adopting new technologies among both patients and providers. Building trust and demonstrating the benefits of POC diagnostics are essential for acceptance. 🔥 Well, you know what they say, 𝐧𝐨𝐭𝐡𝐢𝐧𝐠 𝐰𝐨𝐫𝐭𝐡𝐰𝐡𝐢𝐥𝐞 𝐢𝐬 𝐞𝐯𝐞𝐫 𝐞𝐚𝐬𝐲! Stay with us as we carefully look into all aspects of POC technologies, and showcase great efforts to bring the 𝐡𝐢𝐠𝐡𝐞𝐬𝐭 𝐪𝐮𝐚𝐥𝐢𝐭𝐲 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐭𝐨 𝐞𝐯𝐞𝐫𝐲 𝐩𝐥𝐚𝐜𝐞 𝐚𝐧𝐝 𝐞𝐯𝐞𝐫𝐲 𝐩𝐞𝐫𝐬𝐨𝐧 𝐨𝐧 𝐄𝐚𝐫𝐭𝐡! #EnCartaDiagnostics #PointOfCare  #HealthcareInnovation #SustainableHealthcare #TimeSavingSolutions #MolecularDiagnostics #BetterCareEverywhere

At En Carta Diagnostics, we believe in the transformative power of Point of Care (POC) diagnostics. But what are they exactly, and why are they so crucial? To explore this, we decided to launch our first Linkedin #ECDInsights series, where we will dive into all the aspects of POC diagnostics. We will discuss how innovative technologies and great passion drive this exciting field, as well as the profound promise these advances bring into healthcare. 🔍 𝐓𝐨 𝐬𝐭𝐚𝐫𝐭 𝐢𝐭 𝐨𝐟𝐟 - 𝐰𝐡𝐚𝐭 𝐚𝐫𝐞 𝐏𝐎𝐂 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬? In simple words they are analytical tests conducted at or near the site of patient care. Unlike traditional lab tests that require samples to be sent off to a lab, POC diagnostics provide immediate on site results, enabling faster clinical decision-making and treatment. 💡 𝐖𝐡𝐲 𝐏𝐎𝐂 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐭𝐭𝐞𝐫? 𝐓𝐢𝐦𝐞-𝐒𝐚𝐯𝐢𝐧𝐠: With rapid turnaround times, POC diagnostics significantly speed up the diagnosis and treatment process, leading to better patient outcomes and more efficient healthcare delivery. 𝐂𝐨𝐬𝐭-𝐄𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞: By reducing the need for expensive lab infrastructure and minimizing hospital stays, POC diagnostics can offer a more affordable solution for healthcare providers and patients alike. I𝐧𝐬𝐭𝐢𝐭𝐮𝐭𝐢𝐨𝐧𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐂𝐚𝐫𝐞 𝐑𝐞𝐥𝐢𝐞𝐟: Accessible and highly accurate POC diagnostic tests have the power to provide definitive answers, forging the path for a clear and informed treatment plan. Combined with telehealth solutions, patients can receive high quality healthcare without ever setting foot in a doctor’s office or a hospital, freeing institutional time and resources for cases requiring in person diagnosis and treatment. 📣 𝐇𝐨𝐰 𝐜𝐚𝐧 𝐚𝐥𝐥 𝐭𝐡𝐞𝐬𝐞 𝐛𝐞𝐬𝐭 𝐪𝐮𝐚𝐥𝐢𝐭𝐢𝐞𝐬 𝐛𝐞 𝐚𝐜𝐡𝐢𝐞𝐯𝐞𝐝, 𝐚𝐧𝐝 𝐰𝐡𝐚𝐭 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐏𝐎𝐂 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐧𝐞𝐞𝐝 𝐭𝐨 𝐨𝐯𝐞𝐫𝐜𝐨𝐦𝐞? Stay tuned and follow us for more #ECDInsights! Let’s learn together how cutting-edge deeptech innovations help shape the future of healthcare! #EnCartaDiagnostics #PointOfCare #HealthcareInnovation #SustainableHealthcare #TimeSavingSolutions #MolecularDiagnostics

#50HealthDay Last but not least! We will have the great pleasure to welcome on stage Sacha Loiseau, Marie SOCKEEL, Guillaume Horréard, and Margot Karlikow, PhD, to talk about these amazing 🌟innovations that help guide physician decisions🌟 Come hear about these three entrepreneurial stories! ⏩ From the pharmacy with En Carta Diagnostics, to the anapath lab with Primaa, to the OR with Mauna Kea Technologies! ⏩ From the diagnostic test in its pre-commercialization phase, to the Cellvizio in vivo cellular imaging platform, used by surgeons across the world! 🌐 🚀 (Very last day to register, check the comments for the booking link. Attendance is by reservation only.) 🗓 Wednesday, May 29 🕘 From 8.45 to 12.45 📍 At the heart of Paris #HealthcareInnovation #MedicalTechnology #50PartnersHealthDay #FutureOfHealthcare #Inspiration #Entrepreneurship Jean Roubas Sandrine Egron Adrien Rouanet

📢 Great pitch alert 📢 Our amazing CEO, Guillaume Horréard, will be presenting Viva Technology in Paris tomorrow, May 24th, hosted by DIM BioConvS! 🕒 Join him for his pitch from 3:50 PM to 4:00 PM at the Région Ile de France stand (J33, Hall 1 Paris Expo Porte de Versailles) as he dives into the latest advancements and innovations in the field of diagnostics. This is a fantastic opportunity to gain insights into our groundbreaking work and to learn about the future of healthcare technology. Don't miss this chance to connect with Guillaume and explore how En Carta is shaping the future of diagnostics. See you there! 🌟 More details about the event: https://lnkd.in/d8jBzZqx #VivaTech2024 #HealthcareInnovation #Diagnostics #EnCartaDiagnostics #FutureOfHealthcare

📢 We are thrilled to announce we have secured €1.5M in pre-seed funding to advance diagnostic kit platform for Lyme disease    Our groundbreaking patented molecular diagnostic kit is poised to provide game-changing autonomous Lyme detection in minutes We would like to thank Cédric Curtil from CentraleSupélec Venture, who led the round, and the high-profile business angels who participated. "Today, we have a very robust platform technology leveraged for accuracy, speed and cost, which are key in the Point-of-Care space. As a first step, we are focusing on Lyme disease, where the sizeable patient population, accelerated growth of the problem and need for rapid diagnosis following a tick bite make our product indispensable,” said Guillaume Horréard, CEO at En Carta.   Read the full press release https://lnkd.in/d57-ZtaB   #EnCartans #EnCartaDiagnostics #funding #lymedisease #diagnostics #deeptech  50 Partners 50 Partners Health PC'up - Incubateur ESPCI Paris Paris Biotech Santé

We are thrilled to welcome Maylis Garnier as a fantastic addition to our R&D team! Maylis is a seasoned engineer with a rich background in physics, chemistry and biology. At En Carta, Maylis brings her interdisciplinary expertise to the forefront, to further advance our sampling solutions. Join us in welcoming Maylis as we continue to push the boundaries of diagnostic technology and work towards better care, everywhere. 🚀 #EnCartaDiagnostics #Innovation #HealthcareRevolution #TeamExpansion